| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
-Aminobutyric Acid Up-Regulates the Expression of a Novel Secretogranin-II Messenger Ribonucleic Acid in the Goldfish Pituitary1
Department of Zoology (M.B., P.T.B., V.L.T.), University of Aberdeen, Aberdeen, AB24 2TZ, United Kingdom; Department of Biological Sciences (J.P.C.), University of Alberta, Edmonton, Alberta, T6G 2E9, Canada; and Department of Molecular and Cellular Biology (M.B., P.T.B., K.D.), Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom
Address all correspondence and requests for reprints to: Vance L. Trudeau, Department of Biology, University of Ottawa. P.O. Box 450, Station A. Ottawa, Ontario K1N 6N5, Canada. E-mail: vtrudeau{at}science.uottawa.ca
An RNA-arbitrarily primed PCR differential display strategy was used to
identify candidate genes in the pituitary that are up-regulated by
endogenously activated
-aminobutyric acid (GABA) systems that may
also be involved in the control of reproduction. Goldfish were injected
with the GABA metabolism inhibitor
-vinyl-GABA (GVG), known for its
high efficiency to specifically increase endogenous brain and pituitary
GABA levels in this species, resulting in higher levels of circulating
gonadotropin-II (GTH-II). Several transcripts related to hormone
secretion, signal transduction pathways, and messenger RNA (mRNA)
editing were shown to be up-regulated after GVG injection. Among these
transcripts we characterized an mRNA coding for the secretory vesicle
protein secretogranin-II (SgII), a member of the chromogranin family,
which is the precursor of a novel 34 amino acid neuropeptide, goldfish
secretoneurin (SN). A semiquantitative PCR developed to measure
pituitary SgII mRNA levels showed a 5-fold increase in GVG treated fish
vs. control fish. Moreover, GVG treatment specifically
increased SgII mRNA levels in gonadotrophs, concomitant with a decrease
in GTH-II cell content. In addition, ip injection of synthetic goldfish
SN increased GTH-II release in goldfish pretreated with the dopamine
antagonist domperidone. Activation of GABAergic neurons has two
effects, enhancing in vivo GTH-II release and
up-regulating SgII mRNA specifically in goldfish gonadotrophs. Together
with our SN bioactivity data, this suggests the existence in the
pituitary of an autocrine or paracrine mechanism linked to the
regulated secretory pathway in the gonadotrophs.
This article has been cited by other articles:
![]() |
M. Montero-Hadjadje, G. Pelletier, L. Yon, S. Li, J. Guillemot, R. Magoul, Y. Tillet, H. Vaudry, and Y. Anouar Biochemical Characterization and Immunocytochemical Localization of EM66, a Novel Peptide Derived from Secretogranin II, in the Rat Pituitary and Adrenal Glands J. Histochem. Cytochem., August 1, 2003; 51(8): 1083 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Trudeau, O Kah, J. Chang, B. Sloley, P Dubourg, E. Fraser, and R. Peter The inhibitory effects of (gamma)-aminobutyric acid (GABA) on growth hormone secretion in the goldfish are modulated by sex steroids J. Exp. Biol., January 5, 2000; 203(9): 1477 - 1485. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |